abnormal xenobiotic pharmacokinetics_As3mt<tm1Djth>/As3mt<tm1Djth>

http://metadb.riken.jp/0008875I129S6SvEvTacC57BL6As3mttm1DjthAs3mttm1DjthAs3mttm1Djth

abnormal xenobiotic pharmacokinetics_As3mt<tm1Djth>/As3mt<tm1Djth>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• arsenic (+3 oxidation state) methyltransferase
  http://metadb.riken.jp/db/mgi_rdf/MGI:1929882

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• As3mt<tm1Djth>/As3mt<tm1Djth>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• As3mt<tm1Djth>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal xenobiotic pharmacokinetics
  http://purl.obolibrary.org/obo/MP_0008875

文献

http://purl.org/net/cito/citesAsAuthority

• Zuzana. Drobna, et.al., Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate., Chemical research in toxicology, 2009, 22
  http://rdf.ncbi.nlm.nih.gov/pubmed/19691357